Read the latest news about Alfa Study, the research platform at the Barcelonaβeta Brain Research Center (BBRC) to identify early pathophysicological characteristics of Alzheimer's disease to develop prevention strategies.
Researchers have determined cut-off values that mark the transition from the absence of amyloid pathology to subtle pathology.
BBRC researchers have determined that higher risks of dementia are associated with an increased load of global white matter hyperintensities, which are brain lesions of vascular origin
BBRC researchers have received funding from the Alzheimer’s Association to analyze the possible effect of telomeres, which are considered a biomarker of biological aging, in the disease
Data of the Study Alfa is now available, upon request, on the integrated online research platform launched by the Alzheimer’s Association.
The study has detected that some individuals who perceive subjective cognitive decline have a worse cognitive performance and lower grey matter volumes in areas which are affected by Alzheimer’s disease
The aim of the project, entitled AlfaAge, is to identify pro-ageing and pro-youthful blood biomarkers in different age groups.
The project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie action grant agreement No 752310.
Los resultados de la investigación son fruto del Estudio Alfa, impulsado por la Fundación Bancaria “la Caixa”, y de la colaboración con el Barcelona Supercomputing Center